QTTB | Q32 BioNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$8.76
+$0.05 (+0.57%)

Q32 Bio (QTTB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Oct 2025, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily and between the two on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $8.76 vs 50 $10.15 / 200 $9.29
Projection
Death cross projected in 6 bars
Test
No active test
Last cross
Golden cross 21 Oct 2025 ยท projected 21 bars out

Weekly

No weekly data

4-hour as of 3 Nov 13:30 ET

Price
between the two $8.78 vs 50 $8.40 / 200 $12.45
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 Sep 2026 ยท projected 27 bars out

Cross history

2
crosses on record since 2025
1 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Sep 2026Death4-hour27 bars outNot tested
21 Oct 2025Golden moderatedaily21 bars outNot tested

About QTTB

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.